Join
Live feed
·
INSIDERFilingvia Quantisnow
BridgeBio Pharma Inc. logo

President and CFO Trimarchi Thomas covered exercise/tax liability with 22,781 shares and sold $888,419 worth of shares (13,651 units at $65.08) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 359,194 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.) and more on Quantisnow.